Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 12.

Matter-Walstra, Klazien; Braun, R; Kolb, C; Ademi, Z; Dummer, R; Pestalozzi, B C; Schwenkglenks, Matthias (2016). Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors. British Journal of Dermatology, 174(2):463.

Frauchiger, A L; Mangana, J; Rechsteiner, M; Moch, H; Seifert, Burkhardt; Braun, R; Dummer, R; Goldinger, S M (2016). Prognostic relevance of LDH and serum S-100 levels in Stage IV melanoma with known BRAF mutation status. British Journal of Dermatology, 174(4):823-830.

Matter-Walstra, K; Braun, R; Kolb, C; Ademi, Z; Dummer, R; Pestalozzi, B C; Schwenkglenks, M (2015). A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting. British Journal of Dermatology, 173(6):1462-1470.

Braun, R; Grossniklaus, U; Gygax, D; Kohler, S; Matthias, P; Romeis, J; Sanvido, O; Stieger, P (2013). Gentechnisch veränderte Nutzpflanzen und ihre Bedeutung für eine nachhaltige Landwirtschaft in der Schweiz. Bern: Akademien der Wissenschaften Schweiz.

Kerl, K; Kempf, W; Kamarachev, J; Spallone, G; Braun, R; Wiesner, T; French, L E; Dummer, R (2012). Constitutional Intraepidermal ascent of Melanocytes. A potential pitfall in the diagnosis of Melanocytic Lesions. Archives of Dermatology, 148(2):235-238.

Dummer, R; Goldinger, S; Rinderknecht, J; Eggmann, N; Felderer, L; Braun, R; French, L E (2012). Melanomtherapie - ein Paradigma für die «personalized medicine». Praxis, 101(15):955-959.

Blum, A; Simionescu, O; Argenziano, G; Braun, R; Cabo, H; Eichhorn, A; Kirchesch, H; Malvehy, J; Marghoob, A A; Puig, S; Ozdemir, F; Stolz, W; Tromme, I; Weigert, U; Wolf, I H; Zalaudek, I; Kittler, H (2011). Dermoscopy of pigmented lesions of the mucosa and the mucocutaneous junction: results of a multicenter study by the International Dermoscopy Society (IDS). Archives of Dermatology, 147(10):1181-1187.

Zeyer, A (2011). Fatima’s Rules oder: Muss der naturwissenschaftliche Unterricht neu gedacht werden? In: Bartosch, U; Litfin, G; Braun, R; Neuneck, G. Verantwortung von Wissenschaft und Forschung in einer globalisierten Welt. Forschen - erkennen - handeln. Berlin: LIT Verlag, 333-346.

Dummer, R; Guggenheim, M; Arnold, A W; Braun, R; von Moos, R (2011). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Medical Weekly, 141:w13320.

Menzies, S W; Kreusch, J; Byth, K; Pizzichetta, M A; Marghoob, A; Braun, R; Malvehy, J; Puig, S; Argenziano, G; Zalaudek, I; Rabinovitz, H S; Oliviero, M; Cabo, H; Ahlgrimm-Siess, V; Avramidis, M; Guitera, P; Soyer, H P; Ghigliotti, G; Tanaka, M; Perusquia, A M; Pagnanelli, G; Bono, R; Thomas, L; Pellacani, G; Langford, D; Piccolo, D; Terstappen, K; Stanganelli, I; Llambrich, A; Johr, R (2008). Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Archives of Dermatology, 144(9):1120-1127.

Willi, J P; Matter, M; Buchegger, F; Antonescu, C; Guggisberg, D; Cerottini, J P; Krischer, J; Braun, R; Marie Kurt, A; Roche, B; Lemoine, R; Rimoldi, D; Lejeune, F J; Liénard, D; Bischof Delaloye, A (2007). Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma. Nuklearmedizin, 46(6):244-251.

Braun, R; Fitzi, K; Gutzwiller, Felix; Hohl, H R; van der Linde, François; Gelzer, J (1981). Resistenzhäufigkeit von Escherichia coli in der Schweiz. Swiss Medical Weekly, 111(27-28):1048-1057.

This list was generated on Tue Oct 24 08:12:47 2017 CEST.